Published by
@ShahidNShah
@ShahidNShah
July 23 to July 25, 2024
Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States
The 2nd ADC Toxicity Summit, scheduled from July 23rd to July 25th, 2024, presents a crucial opportunity to address the persistent challenge of toxicities hindering the progression of antibody-drug conjugates (ADCs) to clinical use. With an increasing number of companies entering the ADC arena and heightened competition, understanding translational challenges and off-target toxicities becomes paramount. This summit brings together over 80 colleagues from leading pharmaceutical companies like Pfizer, Merck, ImmunoGen, and others to discuss shared challenges in ADC toxicities, from in vitro to clinical stages. Experts will unveil novel toxicity data, discuss optimal in vivo models, explore biomarker utilization, and introduce innovative strategies to enhance ADC therapeutic index. This event aims to unite the foremost minds in ADC toxicology to offer actionable insights for predicting and mitigating toxicities, driving ADC development forward to address unmet medical needs effectively.
[Read on adc-toxicity.com](https://adc-toxicity.com/take-part/register/)
Continue reading at adc-toxicity.com
July 23 to July 24, 2024
The Westin Boston Seaport District, 425 Summer Street, Boston, Massachusetts, 02210, United States
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Dec 18, 2024 at 12:33pm